APA (7th ed.) Citation

S, M., K, Y., A, K., T, U., Y, M., T, K., & Y, U. (2026). Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report. Journal of palliative medicine, 29(4), 557. https://doi.org/10.1177/10966218251385732

Chicago Style (17th ed.) Citation

S, Murakami, Yamagishi K, Kitani A, Ueta T, Matsuura Y, Kubota T, and Uezono Y. "Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report." Journal of Palliative Medicine 29, no. 4 (2026): 557. https://doi.org/10.1177/10966218251385732.

MLA (9th ed.) Citation

S, Murakami, et al. "Gefapixant Citrate, a Selective P2X3 Receptor Antagonist, May Improve Cancer-Related Hypergeusia: A Case Report." Journal of Palliative Medicine, vol. 29, no. 4, 2026, p. 557, https://doi.org/10.1177/10966218251385732.